← Leaderboards
Harlan Linver Pietz
Weill Medical Coll Of Cornell Univ
$189,037
Attributed
$189,037
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$189,037 · 1
By mechanism
F30$189,037 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Colleen E Clancy$12,823,774
- Briana Glyn Nixon$133,584
- Tracy A. Butler$6,223,307
- Gloria Chia-Yi Chiang$5,402,243
- Paul Young$54,538
Others in their field
Other Emerging Leaders on “Complement Component C4a”
- Gyungah Jun · University Of Pennsylvania$532,090
- Hisashi Akiyama · Boston University Medical Campus$464,612
- Rajiv Radhakrishnan · Yale University$220,500
- Minsoo Kim · University Of California Los Angeles$37,894
Research focus
Complement Component C4aComplexCommunicationAntioxidantsAbcb1 GeneAtp-Binding Cassette TransportersAntineoplastic AgentsAmericanBinding SitesBiochemicalAmino AcidsCareerCattleCell MembraneCellsCellular AssayBindingCharacteristicsChargeChemotherapeutic AgentChildChildhood Extracranial Solid TumorBiophysicsCoupled
Grant awards (4)
Studies of the structural and functional basis of neuroblastoma drug resistance$33,555
F30 · FY2024 · CA · contact PI
Studies of the structural and functional basis of neuroblastoma drug resistance$52,694
F30 · FY2023 · CA · contact PI
Studies of the structural and functional basis of neuroblastoma drug resistance$51,752
F30 · FY2022 · CA · contact PI
Studies of the structural and functional basis of neuroblastoma drug resistance$51,036
F30 · FY2021 · CA · contact PI